# MiNK Therapeutics, Inc.: Form SC 13D, filed Feb 14, 2024

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: SC 13D
- Filed: 2024-02-14
- Accepted by EDGAR: Feb 14, 2024, 23:05 ET
- Period: not reported
- Accession: 0001193125-24-036660
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000119312524036660/d763069dsc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000119312524036660/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000119312524036660/d763069dsc13d.htm

Filed Feb 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-036660. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.